Clinical Trial


A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer


Brief description

The purpose of this study is to assess the analgesic efficacy of flexibly-dosed pregabalin in the adjunctive treatment of subjects with cancer-induced bone pain.

Detailed Description

Pfizer decided to discontinue additional enrollment into the study effective Sept 5 2010 after assessing the feasibility of completing this study in a realistic timeframe.The study was not stopped for any safety concerns.

Keywords

  •   Bone Neoplasms
  •   Cancer
  •   Pain, Intractable

Sponsored By

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Unique Study ID

NCT00381095

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

AbbVie
34747-4970, Celebration, Florida, United States
Distance from Current Trial is 0 miles

Carlos A. Alemany

Southwest Oncology Group
34747, Celebration, Florida, United States
Distance from Current Trial is 0 miles

No Investigator Listed

AstraZeneca
34747, Celebration, Florida, United States
Distance from Current Trial is 0 miles
View All